Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony P Adamis

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Retina (Philadelphia, Pa.)|June 26, 2009
The rationale for drug combinations in age-related macular degenerationAnthony P Adamis
Ophthalmology Clinics of North America|August 29, 2006
Molecular biology of choroidal neovascularizationMing Lu, Anthony P Adamis
International Ophthalmology Clinics|June 24, 2004
Ocular delivery of angiostatic agentsMing Lu, Anthony P Adamis
Progress in Retinal and Eye Research|June 14, 2002
Transscleral drug delivery to the retina and choroidJayakrishna Ambati, Anthony P Adamis
Ophthalmology Clinics of North America|June 18, 2002
Vascular endothelial growth factor gene regulation and action in diabetic retinopathyMing Lu, Anthony P Adamis
Nature Reviews. Drug Discovery|January 19, 2016
Ten years of anti-vascular endothelial growth factor therapyNapoleone Ferrara, Anthony P Adamis
Advances in Experimental Medicine and Biology|August 17, 2010
The case for complement and inflammation in AMD: open questionsNatalia Karagianni, Anthony P Adamis
Seminars in Ophthalmology|May 14, 2009
Judah FolkmanAnthony P Adamis, Joan W Miller
Seminars in Immunopathology|March 15, 2008
Immunological mechanisms in the pathogenesis of diabetic retinopathyAnthony P Adamis, Adrienne J Berman
Developments in Ophthalmology|October 27, 2015
Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other FactorsRoman G Rubio, Anthony P Adamis
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Retina (Philadelphia, Pa.)|June 26, 2009
The rationale for drug combinations in age-related macular degenerationAnthony P Adamis
Ophthalmology Clinics of North America|August 29, 2006
Molecular biology of choroidal neovascularizationMing Lu, Anthony P Adamis
International Ophthalmology Clinics|June 24, 2004
Ocular delivery of angiostatic agentsMing Lu, Anthony P Adamis
Progress in Retinal and Eye Research|June 14, 2002
Transscleral drug delivery to the retina and choroidJayakrishna Ambati, Anthony P Adamis
Ophthalmology Clinics of North America|June 18, 2002
Vascular endothelial growth factor gene regulation and action in diabetic retinopathyMing Lu, Anthony P Adamis
Nature Reviews. Drug Discovery|January 19, 2016
Ten years of anti-vascular endothelial growth factor therapyNapoleone Ferrara, Anthony P Adamis
Advances in Experimental Medicine and Biology|August 17, 2010
The case for complement and inflammation in AMD: open questionsNatalia Karagianni, Anthony P Adamis
Seminars in Ophthalmology|May 14, 2009
Judah FolkmanAnthony P Adamis, Joan W Miller
Seminars in Immunopathology|March 15, 2008
Immunological mechanisms in the pathogenesis of diabetic retinopathyAnthony P Adamis, Adrienne J Berman
Developments in Ophthalmology|October 27, 2015
Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other FactorsRoman G Rubio, Anthony P Adamis
Pageof 7